Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
A mathematical program developed by Princeton researchers is able to scan through scores of potential peptide drug candidates, accelerating pharmaceutical development.
A team of Rice University students uses augmented reality to create a walking aid for Parkinson’s disease patients with freezing of gait. The team developed a smartphone app…
